US5189021A
(en)
*
|
1979-09-21 |
1993-02-23 |
Roussel Uclaf |
Method of treating precocious puberty
|
US5389613A
(en)
*
|
1979-09-21 |
1995-02-14 |
Roussel Uclaf |
Method of treating prostate adenocarcinoma, prostate benign hypertrophia and endometriosis
|
FR2465486A1
(fr)
*
|
1979-09-21 |
1981-03-27 |
Roussel Uclaf |
Nouvelle application utilisant la lh-rh ou des agonistes
|
US4443368A
(en)
*
|
1982-11-01 |
1984-04-17 |
The Salk Institute For Biological Studies |
Peptides affecting gonadal function
|
ZA838780B
(en)
*
|
1982-11-26 |
1985-01-30 |
Nyegaard & Co As |
Peptide compounds
|
NZ206518A
(en)
*
|
1982-12-10 |
1989-06-28 |
Syntex Inc |
Nasal composition comprising nona- or deca-peptide lhrh analogue and bile acid surfactant
|
JPS59225113A
(ja)
*
|
1983-06-07 |
1984-12-18 |
Japan Atom Energy Res Inst |
徐放性複合体およびその製造方法
|
ZA845550B
(en)
*
|
1983-08-09 |
1986-03-26 |
American Home Prod |
Treatment of endometriosis
|
DE3332329A1
(de)
*
|
1983-09-08 |
1985-03-28 |
Hoechst Ag, 6230 Frankfurt |
Verwendung von gonadoliberin und gonadoliberinagonisten zur behandlung von stoffwechselerkrankungen, die auf zu geringe parathormonspiegel zurueckzufuehren sind
|
DE3414595A1
(de)
*
|
1984-04-18 |
1985-10-31 |
Hoechst Ag, 6230 Frankfurt |
Verwendung von gonadoliberin und gonadoliberinagonisten zur behandlung klimakterischer beschwerden
|
US4632979A
(en)
*
|
1984-06-18 |
1986-12-30 |
Tulane Educational Fund |
Therapeutic LHRH analogs
|
US4760053A
(en)
*
|
1984-08-02 |
1988-07-26 |
Fernand Labrie |
Combination therapy for selected sex steroid dependent cancers
|
US4666885A
(en)
*
|
1985-02-08 |
1987-05-19 |
Fernand Labrie |
Combination therapy for treatment of female breast cancer
|
US4775660A
(en)
*
|
1984-08-02 |
1988-10-04 |
Fernand Labrie |
Treatment of breast cancer by combination therapy
|
US4690916A
(en)
*
|
1984-11-13 |
1987-09-01 |
Syntex (U.S.A.) Inc. |
Nona and decapeptide analogs of LHRH useful as LHRH antagonists
|
HU194280B
(en)
*
|
1985-10-22 |
1988-01-28 |
Richter Gedeon Vegyeszet |
Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
|
DE3634435A1
(de)
*
|
1986-10-09 |
1988-04-14 |
Hoechst Ag |
Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
|
IT1214735B
(it)
*
|
1986-11-04 |
1990-01-18 |
Roussel Maestretti Spa |
Impiego di 1-(3'-trifluorometil 4'nitrofenil) 4,4-dimetilimidazolin2,5-dione per il trattamento di cancri ormonodipendenti diverso da quello della prostata
|
GB8713240D0
(en)
*
|
1987-06-05 |
1987-07-08 |
Proteus Biotech Ltd |
Hormones
|
EP0312052B1
(fr)
*
|
1987-10-15 |
1994-01-05 |
Syntex (U.S.A.) Inc. |
Compositions pour l'administation nasale des polypeptides en poudre
|
US4895715A
(en)
*
|
1988-04-14 |
1990-01-23 |
Schering Corporation |
Method of treating gynecomastia
|
US5395842A
(en)
*
|
1988-10-31 |
1995-03-07 |
Endorecherche Inc. |
Anti-estrogenic compounds and compositions
|
US5204337A
(en)
*
|
1988-10-31 |
1993-04-20 |
Endorecherche Inc. |
Estrogen nucleus derivatives for use in inhibition of sex steroid activity
|
US5686465A
(en)
*
|
1988-10-31 |
1997-11-11 |
Endorecherche Inc. |
Sex steroid activity inhibitors
|
EP0462189B1
(fr)
*
|
1989-03-10 |
1995-09-27 |
Endorecherche Inc. |
Therapie combinee pour le traitement de maladies sensibles a l'oestrogene
|
US5364847A
(en)
*
|
1989-03-10 |
1994-11-15 |
Endorecherche |
Inhibitors of sex steroid biosynthesis and methods for their production and use
|
US5372996A
(en)
*
|
1989-03-10 |
1994-12-13 |
Endorecherche, Inc. |
Method of treatment of androgen-related diseases
|
US5595985A
(en)
|
1989-03-10 |
1997-01-21 |
Endorecherche Inc. |
Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
|
US5068221A
(en)
*
|
1989-05-09 |
1991-11-26 |
Mathias John R |
Treatment of motility disorders with a gnrh analog
|
CA2062973C
(fr)
*
|
1989-07-07 |
2003-09-23 |
Fernand Labrie |
Therapie combinee pour la prophylaxie et/ou le traitement de l'hyperplasie benigne de la prostate
|
WO1991000733A1
(fr)
*
|
1989-07-07 |
1991-01-24 |
Endorecherche Inc. |
Procede de traitement des maladies associees aux androgenes
|
WO1991004040A1
(fr)
*
|
1989-09-15 |
1991-04-04 |
Biomeasure, Inc. |
Traitement de cancer du colon
|
US5434136A
(en)
*
|
1990-12-14 |
1995-07-18 |
Mathias; John R. |
Treatment of motility disorders with a GNRH analog
|
ZA924811B
(en)
*
|
1991-06-28 |
1993-12-29 |
Endorecherche Inc |
Controlled release systems and low dose androgens
|
HU222501B1
(hu)
*
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
US6060503A
(en)
*
|
1991-12-02 |
2000-05-09 |
Endorecherche, Inc. |
Benzopyran-containing compounds and method for their use
|
WO1993023053A1
(fr)
*
|
1992-05-21 |
1993-11-25 |
Endorecherche Inc. |
INHIBITEURS D'ACTIVITE DE LA TESTOSTERONE 5α-REDUCTASE
|
US6090925A
(en)
*
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
*
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6187345B1
(en)
|
1998-04-14 |
2001-02-13 |
Jack Lawrence James |
Flutamide compositions and preparations
|
HUP0103761A3
(en)
*
|
1998-10-08 |
2002-11-28 |
Takeda Chemical Industries Ltd |
Compositions for retarding change of hormone-dependent cancer into hormone-independent cancer and their use
|
JP2002533387A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー.ディー.サール & カンパニー |
腫瘍治療の複合療法としてインテグリン拮抗物質と一つ以上の抗腫瘍剤を使用する方法
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US6649645B1
(en)
*
|
1998-12-23 |
2003-11-18 |
Pharmacia Corporation |
Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
|
FR2791573B1
(fr)
*
|
1999-03-30 |
2003-04-11 |
Pf Medicament |
Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
|
US20050042679A1
(en)
*
|
1999-04-15 |
2005-02-24 |
Monash University |
Diagnostic indicator of thymic function
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
FR2804321B1
(fr)
*
|
2000-01-28 |
2003-08-15 |
Oreal |
Utilisation de derives de polyaminoacides pour traiter la seborrhee et les desordres cutanes associes
|
TWI270545B
(en)
|
2000-05-24 |
2007-01-11 |
Sugen Inc |
Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
|
CA2413417A1
(fr)
*
|
2000-06-28 |
2002-01-03 |
Bristol-Myers Squibb Company |
Modulateurs selectifs des recepteurs androgeniques et leurs methodes d'identification, d'elaboration et d'utilisation
|
US20040077605A1
(en)
*
|
2001-06-20 |
2004-04-22 |
Salvati Mark E. |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
US7001911B2
(en)
|
2000-06-28 |
2006-02-21 |
Bristol-Myers Squibb Company |
Fused cyclic modulators of nuclear hormone receptor function
|
EP1854798A3
(fr)
*
|
2000-09-19 |
2007-11-28 |
Bristol-Myers Squibb Company |
Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire
|
US6953679B2
(en)
|
2000-09-19 |
2005-10-11 |
Bristol-Myers Squibb Company |
Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
|
CN1406131A
(zh)
*
|
2000-12-25 |
2003-03-26 |
株式会社资生堂 |
活化交感神经的香料组合物
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US20040087548A1
(en)
|
2001-02-27 |
2004-05-06 |
Salvati Mark E. |
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
US6479692B1
(en)
*
|
2001-05-02 |
2002-11-12 |
Nobex Corporation |
Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
WO2003015820A1
(fr)
*
|
2001-08-10 |
2003-02-27 |
Takeda Chemical Industries, Ltd. |
Medicaments combines d'agoniste de la gnrh
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6770625B2
(en)
*
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
JP3908501B2
(ja)
|
2001-10-12 |
2007-04-25 |
株式会社テーアンテー |
ルームランプの固定構造
|
JP3908500B2
(ja)
|
2001-10-12 |
2007-04-25 |
株式会社テーアンテー |
ルームランプの固定構造
|
US20040043938A1
(en)
*
|
2001-11-06 |
2004-03-04 |
Dinesh Purandare |
Combination therapy for estrogen-dependent disorders
|
US7087636B2
(en)
*
|
2001-12-19 |
2006-08-08 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
|
AU2002367424A1
(en)
*
|
2001-12-28 |
2003-07-24 |
Takeda Chemical Industries, Ltd. |
Androgen receptor antagonists
|
EP2316468A1
(fr)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Système de distribution et méthodes de protection et d'administration de dextroamphetamine
|
EP1488807A4
(fr)
*
|
2002-03-11 |
2009-07-08 |
Takeda Pharmaceutical |
Medicaments permettant de traiter une maladie dependant d'une hormone sexuelle
|
WO2003105768A2
(fr)
*
|
2002-06-13 |
2003-12-24 |
Nobex Corporation |
Methodes de reduction du nombre et de la gravite des episodes hypoglycemiques dans le traitement du diabete sucre
|
NZ553263A
(en)
|
2004-07-19 |
2010-06-25 |
Biocon Ltd |
Insulin-oligomer conjugates, formulations and uses thereof
|
US20080245375A1
(en)
*
|
2007-04-05 |
2008-10-09 |
Medtronic Vascular, Inc. |
Benign Prostatic Hyperplasia Treatments
|
WO2009050738A2
(fr)
|
2007-10-16 |
2009-04-23 |
Biocon Limited |
Composition pharmaceutique solide administrable par voie orale et procédé associé
|
US12011423B2
(en)
|
2007-11-06 |
2024-06-18 |
Foraviset Ltd. |
S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
|
EP2266567A1
(fr)
|
2009-05-26 |
2010-12-29 |
Æterna Zentaris GmbH |
Composition pharmaceutique comprenant de Cetrorelix e d'inhibiteurs de PDE V pour le traitement des étas dépendants de l'hormone sexuel
|
EP2266568A1
(fr)
|
2009-05-26 |
2010-12-29 |
Æterna Zentaris GmbH |
Composition pharmaceutique comprenant d'antagonistes de LHRH et d'inhibiteurs de PDE V pour le traitement des états dépendants de l'hormone sexuel
|
US20160361380A1
(en)
|
2015-06-12 |
2016-12-15 |
Nymox Corporation |
Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
US10335453B2
(en)
|
2017-03-01 |
2019-07-02 |
Nymox Corporation |
Compositions and methods for improving sexual function
|